Alimera racks up another Iluvien approval with German nod
This article was originally published in Scrip
Executive Summary
Alimera Sciences has gained its fifth national approval in Europe approval for Iluvien (fluocinolone acetonide) as the Federal Ministry of Health of Germany today granted marketing authorisation for the treatment of vision impairment associated with chronic diabetic macular oedema.